Skip to content
APDN and EvviVax Announce Publication of Positive Preclinical Data for LinearDNA™ Platform Approach to Cancer Immunotherapy
February 17, 2022
Read More email
Research Publication Demonstrates Utility of APDN’s LinearDNA™ in Non-Viral CAR T Manufacturing Systems
November 9, 2021
Read More email
Research Publication Demonstrates Utility of APDN’s LinearDNA™ in Non-Viral CAR T Manufacturing
November 9, 2021
Read More email
APDN Announces Linear DNA Orders from New Contract Research Customers for Use in RNA Vaccine and Adeno-Associated Virus Applications
November 2, 2020
Read More email
APDN Ships LinearDNA™ to Another Development Customer
March 26, 2020
Read More email
APDN Secures Top-20 Pharmaceutical Manufacturer as Drug Development Customer
March 20, 2020
Read More email
Medicare Coverage of CAR T-Cell Therapy Holds Positive Implications for LineaRx
August 12, 2019
Read More email
LineaRx Achieves Anti-CD19 Expression in Human CAR T Cells via Plasmid-Free Platform
April 8, 2019
Read More email
LineaRx to Announce DNA Vaccine Preclinical Data and Efficacy of In-Licensed CAR T Therapy
December 4, 2018
Read More email
At LineaRX, Putting The Horsepower Behind The CAR T
October 17, 2018
Read More email
Non-Viral, Plasmid-Free CAR T-Manufacturing Platform Begins Preclinicals
October 16, 2018
Read More email
LineaRx Licenses CAR T Drug Candidate, Initiates Pre-Clinical Development of Non-viral, Plasmid-free CAR T Manufacturing Platform
October 16, 2018
Read More email
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Ok 
